Cargando…
ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'S*
Recent decades have seen a growth in treatments for attention deficit hyperactivity disorder (ADHD) including many branded and generic drugs. In the early 2000's, new drug entry dramatically altered market shares. We estimate a demand system for ADHD drugs and assess the welfare impact of new d...
Autores principales: | Bokhari, Farasat A S, Fournier, Gary M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373170/ https://www.ncbi.nlm.nih.gov/pubmed/25821242 http://dx.doi.org/10.1111/joie.12017 |
Ejemplares similares
-
Differentiated Entry or “Me-Too” Entry in Bertrand and Cournot Oligopoly
por: Brander, James A., et al.
Publicado: (2021) -
The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021) -
Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018) -
Me, Too
por: Gyawali, Bishal
Publicado: (2016) -
Drugs Becoming Generics—The Impact of Genericization on the Market Performance of Antihypertensive Active Pharmaceutical Ingredients
por: Kovács, Bence, et al.
Publicado: (2021)